NEW YORK — Healthcare company Centene said on Wednesday that it has signed an agreement to help distribute Quest Diagnostics SARS-CoV-2 test kits in the US.
According to St. Louis-based Centene, it will facilitate the distribution of 25,000 of Quest's rRT-PCR-based SARS-CoV-2 test kits each week to Federally Qualified Health Centers in 10 US states or districts, beginning on May 4. Centene said it will also provide oversight and training to ensure the test kits are received and processed properly.
Quest will perform the tests at its network laboratories.